Mini Review
Volume 5 Issue 4 - 2021
Obese Treatments, New Ideas and Avenues
Jin-Yu Che, Hong-Ying Wu, Bin Xu and Da-Yong Lu*
School of Life Science, Shanghai University, Shanghai, China
*Corresponding Author: Da-Yong Lu, School of Life Science, Shanghai University, Shanghai, China.
Received: April 07, 2021; Published: April 28, 2021




Abstract

Obesity is an annoying metabolic phenotype that is attributed to a number of different patho-physiological risk factors. For obese people, life-style management, drugs and surgery are the major selections for recovering their healthy forms. Since a great diversity of risk factors can trigger human features of obesity, personalized medicine (biomarkers and genetic alteration) or others are one of future obesity treatments. This article briefly reviews these pathologic or therapeutic insights.

Keywords: Obesity; Endocrinology; Human Genome; Inflammatory Factors; Mental Disorder; Metabolic Disorders

References

  1. World Health Organization. WHO, Obesity and overweight (2018).
  2. Lu DY., et al. “Obesity, risks and managements”. Metabolomics1 (2018): e155.
  3. Lu DY., et al. “An overview of obesity”. Metabolomics2 (2018): 200.
  4. Jainta N., et al. “Infection diseases and vaccination in patients with diabetes”. EC Diabetes and Metabolic Research3 (2019): 91-97.
  5. Lu DY., et al. “Pathology and treatments of obesity”. Trends in Medicine5 (2018): 157.
  6. Lu DY., et al. “Obese study, keep up the momentum”. International Journal of Endocrinology and Research1 (2018): 4-8.
  7. Brestoff JJR and Artis D. “Immune regulation of metabolic homeostasis in health and disease”. Cell 161 (2015): 146-160.
  8. Yanai H. “VLDL is the leading actor in lipid abnormality in patients with diabetes and obesity”. Journal of Endocrinology and Metabolism4 (2017): 101-102.
  9. Steculorum SM., et al. “Hypothalamic UDP increases in obesity and promotes feeding via P2Y6-dependent activation of AgRP neurons”. Cell 162 (2015): 1404-1417.
  10. Lee YS., et al. “Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity”. Cell 157 (2014): 1339-1352.
  11. Quarta C., et al. “Epigenetic ON/OFF switches for obesity”. Cell 164 (2016): 341-342.
  12. Dalgaard K., et al. “Trim28 haploinsufficiency triggers bi-stable epigenetic obesity”. Cell 164 (2016): 353-364.
  13. Lu DY., et al. “Mini-review of obesity, etiology progresses and different therapeutics”. EC Diabetes and Metabolic Research3 (2019): 98-102.
  14. Lu DY., et al. “Human obesity, pathological and therapeutic advances”. EC Pharmacology and Toxicology4 (2019): 231-238.
  15. Singh A., et al. “Protective role of Terminalia Chebula in streptozotocin-induced diabetic mice for wound healing activity”. British Journal of Medicine and Medical Research2 (2017): 1-8.
  16. Smith RE., et al. “Dietary carbohydrates that modulate the immune system”. Clinical Immunology, Endocrine and Metabolic Drugs1 (2015): 35-42.
  17. Nzuza S., et al. “Highly active antiretroviral therapy—associated metabolic syndrome and lipodystrophy: pathophysiology and current therapeutic interventions”. Journal of Endocrinology and Metabolism4 (2017): 103-116.
  18. Sgrawai P. “An overview on adverse drug reactions”. EC Pharmaceutical Science1 (2015): 181-182.
  19. Correa-Giannella ML and Machado UF. “SLC2A4 gene: a promising target for pharmacogenomics of insulin resistance”. Pharmacogenomics8 (2013): 847-850.
  20. Brettdeld C., et al. “Micro RNAs responsible for inflammation in obesity”. Journal of Endocrinology and Metabolism3 (2017): 77-85.
  21. Van der Klaauw AA and Farooqi IS. “The hunger genes: pathways to obesity”. Cell 161 (2015): 119-132.
  22. Schwartz S. “Psychiatry, psychology and climate change”. EC Psychology Psychiatry7 (2019): 574-576.
  23. Moisan MP., et al. “Transcriptomic signaling pathways involved in a naturalistic model of inflammation-related depression and its remission”. Translational Psychiatry 11 (2021): 203.
  24. Putta S., et al. “Diabetes mellitus and male aging, pharmacotherapeutics and clinical implications”. Current Pharmaceutical Design41 (2017): 6321-6346.
  25. Saxene M., et al. “Anti-diabetic drugs and their effect in T2DM management”. EC Diabetes and Metabolic Research11 (2020): 56-61.
  26. Lu DY., et al. “Keep up the pace of drug development evolution and expenditure”. Cancer Reports and Reviews5 (2018): 165.
  27. Lu DY., et al. “Drug combination in clinical cancer treatment”. Reviews on Recent Clinical Trials3 (2017): 202-211.
  28. Lu DY., et al. “Anticancer drug combinations, studies from different pathways”. Cell and Developmental Biology5 (2015) 166.
  29. Lu DY., et al. “Anticancer drug combination, how far we can go through?” Anti-Cancer Agents in Medicinal Chemistry1 (2017): 21-28.
  30. Putta S and Kilari EK. “A review on methods of estimation of advanced glycation end products”. World Journal of Pharmaceutical Research9 (2015): 689-699.
  31. Lu DY., et al. “Human obesity management, pathways and therapeutics beyond metabolic limitation”. EC Diabetes Metabolic Research4 (2019): 106-108.
  32. Lu DY., et al. “Human obesity therapeutics, modern diagnosis and biomarker”. EC Pharmacology Toxicology9 (2019): 997-1000.
  33. Putta S., et al. “Anthocyanins: Possible role as multitarget therapeutic agents for prevention and therapy of chronic diseases”. Current Pharmaceutical Design30 (2017): 4475-4483.
  34. Lu DY., et al. “Type 2 diabetes study, introduction and perspective”. The Open Diabetes Journal 8 (2018): 13-21.
  35. Lu DY., et al. “Type 2 diabetes treatment and drug development study”. The Open Diabetes Journal 8 (2018): 22-33.
  36. Lu DY., et al. “Discover natural chemical drugs in modern medicines”. Metabolomics3 (2016): 181.
  37. Lu DY and Lu TR. “Drug discoveries from natural resources”. Journal Primary Health Care and General Practice 1 (2019): 28.
  38. Lu DY and Lu TR. “Herbal medicine in new era”. Hospice Palliative Medicine International Journal4 (2019): 125-130.
  39. Lu DY., et al. “Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination-an effective strategy to improve clinical treatment”. Medical Hypotheses1 (2006): 45-51.
  40. Lu DY. “Personalized cancer chemotherapy, an effective way for enhancing outcomes in clinics. Woodhead Publishing, Elsevier, UK (2014).
  41. Lu DY and Lu TR. “Drug sensitivity testing, a unique drug selection strategy”. Advances in Biomarker Sciences and Technology 2 (2020): 59-66.
  42. Lu DY., et al. “Cancer bioinformatics for update anticancer drug developments and personalized therapeutics”. Reviews on Recent Clinical Trials2 (2017): 101-110.
  43. Lu DY., et al. “Patient’s care and nursery in different diseases”. Hospice and Palliative Medicine International Journal1 (2019): 28-30.
  44. Lu DY., et al. “Patient’s care and nursery in modern medicine”. Nursery Practice and Health Care1 (2019): 101.
  45. Lu DY., et al. “Nursery education, narrow-range or wide-range”. Nursing and Care Open Access Journal4 (2020): 87-89.
  46. Lu DY., et al. “Nursery service, quality promotion”. Hospice and Palliative Medicine International Journal3 (2019): 97-98.
  47. Lu DY., et al. “Nursery education in schools, significance for career”. Biomedical Research and Clinical Reviews 2 (2019): 113.
Citation: Da-Yong Lu., et al. “Obese Treatments, New Ideas and Avenues”. EC Diabetes and Metabolic Research 5.4 (2021): 39-43.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the December issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 17, 2021.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk